Please login to the form below

Not currently logged in
Email:
Password:

Dan Zabrowski takes over as head of Roche Applied Science

Former global head of partnering succeeds Paul Brown

Dan Zabrowski - RocheRoche's Dan Zabrowski has assumed his new role as head of Roche Applied Science within the company's diagnostics division.

Zabrowski was previously global head of partnering at Roche and also sat on both the Roche corporate executive committee and the board of Roche's Japan-based subsidiary Chugai.

He will succeed Paul Brown, who has been in charge at Roche Applied Science since September 2011, and will relocate from Basel, Switzerland, to Penzberg, Germany. Once there Brown will remain head of Roche Molecular Diagnostics.

Zabrowski joined Syntex in 1993, before Roche acquired the company in 1994.

He has been with Roche ever since, holding a number of management positions in regulatory affairs and pharma development. He also holds a PhD in organic chemistry from the University of Indiana.

Roche CEO Severin Schwan said: “As head of applied science, Dan will be key for driving this strategically important business with our customers in academia, biotech and pharmaceutical industries.”

As previously announced, general manager of Roche Pharma in France Sophie Kornowski-Bonnet will take over Zabrowski's old role as head of partnering and relocate to the company's Basel-based headquarters.

2nd February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics